@FierceMedDev: Navidea's losses widen as it waits for Lymphoseek to catch on. Article | Follow @FierceMedDev
@DamianFierce: Israel's Given Imaging had a record Q2 and believes better things are on the horizon. Report | Follow @DamianFierce
> Bacterin ($BONE) swung to a net loss of $2.5 million last quarter despite a slight uptick in revenue, but Dan Goldberger, the company's newly appointed CEO, said the implant producer is on track for future growth. Results | CEO appointment
> Tryton Medical is kicking off a physician education program to expand the adoption of its stent for bifurcation lesions. More
> Fresh off its $54 million IPO, NanoString ($NSTG) is expecting between $29.5 million and $31.5 million in revenue for 2013, good for up to 37% growth. Financials
> Singapore's Biosensors watched its revenue slip more than 11% to $76.7 million last quarter, a decline the company blames on a drop in royalty and licensing dollars. Item
> Alabama's Diatherix Laboratories has acquired the patent to a multipurpose diagnostic technology from Qiagen ($QGEN). News
> Medtronic ($MDT) has launched an MRI-safe version of its RestoreSensor neurostimulation system, a device designed to treat chronic pain. Release
Biotech News
@FierceBiotech: Report: Seattle biotech VLST unloads assets and shuts doors. More | Follow @FierceBiotech
@JohnCFierce: Acceleron pitches $75M IPO as Celgene pushes partnership through PhII. News | Follow @JohnCFierce
@RyanMFierce: Now that "microbiome" means something to people... NuMe Health changes name to MicroBiome Therapeutics. Release | Follow @RyanMFierce
> Vaxart garners $20M VC round for vaccine pills. Item
> Report: Determined Amgen sweetens its bid for Onyx Pharma. Story
> FDA experts give Bayer's riociguat unanimous backing for lung disease. Article
Pharma News
@FiercePharma: Looking for a sales job? Lundbeck to hire > 200 to market antidepressant Brintellix, in prep for FDA nod. More | Follow @FiercePharma
@CarlyHFierce: In Vivus earnings, not a lot of revenue, but analysts seem optimistic about Zook's plans for Qsymia. Release | Follow @CarlyHFierce
> Novartis' ambitions for Afinitor suffer on liver-cancer failure. More
> Valeant CEO: Merger of equals still on the table. Story
> China revokes patent on Gilead's Viread. Article
Biomarkers News
> Biomarker IDs cancer patients most likely to respond to EGFR inhibitors. Item
> NIH pushes for biomarker research to catch up with needs of kids. Story
> Are cancer biomarker tests grossly underused? More
> Elevated carbon monoxide levels in breath can point to infection. Story
> Broad, Dana-Farber license lung cancer biomarker IP to MolecularMD. Article
> Altered enzyme indicates Alzheimer's-like dementia. Item
Drug Delivery News
@MichaelGFierce: "Soft robotic" hydrogel arms show drug delivering capability. More | Follow @MichaelGFierce
> UCSD surgeons deliver cancer drugs to brain with ClearPoint MRI tech. Story
> 3M sells dry powder inhaler rights to Adamis. News
> Next-gen Alzheimer's drug targets brain enzyme. Story
> Ocular Therapeutix nets FDA panel meeting for eye surgery hydrogel. Item
> Halozyme regrouping after ViroPharma trial flop. Article